Literature DB >> 1661364

T-cell immune response to human herpesvirus-6 in healthy adults.

Y Yakushijin1, M Yasukawa, Y Kobayashi.   

Abstract

The proliferative response of peripheral blood mononuclear cells (PBMC) from healthy adults to human herpesvirus-6 (HHV-6) was examined. It was found that PBMC from 13 of 14 HHV-6-seropositive adults apparently proliferated in response to stimulation with HHV-6 antigen in contrast to the lack of response of cord blood mononuclear cells. In order to confirm the presence of HHV-6-specific memory T cells in the peripheral blood of healthy adults, we established HHV-6-specific T-cell clones from an HHV-6-seropositive individual. CD4+ T-cell clones generated from HHV-6-stimulated PBMC were found to proliferate upon stimulation with HHV-6 in the presence of autologous antigen-presenting cells, but not in response to herpes simplex virus type 1 antigen or mock-infected control antigen. These results indicate that a T-cell immune response against HHV-6 infection is generally present in healthy adult populations.

Entities:  

Mesh:

Year:  1991        PMID: 1661364     DOI: 10.1111/j.1348-0421.1991.tb01597.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Human herpesvirus 7 infection of lymphoid and myeloid cell lines transduced with an adenovirus vector containing the CD4 gene.

Authors:  M Yasukawa; Y Inoue; H Ohminami; E Sada; K Miyake; T Tohyama; T Shimada; S Fujita
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 2.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

3.  Human CD4+ T cell response to human herpesvirus 6.

Authors:  Maria-D Nastke; Aniuska Becerra; Liusong Yin; Omar Dominguez-Amorocho; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

4.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.

Authors:  Ulrike Gerdemann; Laura Keukens; Jacqueline M Keirnan; Usha L Katari; Chinh T Q Nguyen; Anne P de Pagter; Carlos A Ramos; Alana Kennedy-Nasser; Stephen M Gottschalk; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Ann M Leen
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

6.  Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus.

Authors:  M Yasukawa; Y Yakushijin; M Furukawa; S Fujita
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones.

Authors:  Y Yakushijin; M Yasukawa; Y Kobayashi
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis.

Authors:  Elisabetta Caselli; Maria Chiara Zatelli; Roberta Rizzo; Sabrina Benedetti; Debora Martorelli; Giorgio Trasforini; Enzo Cassai; Ettore C degli Uberti; Dario Di Luca; Riccardo Dolcetti
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

9.  Identification of novel CD8+ T cell epitopes in human herpesvirus 6B U11 and U90.

Authors:  Mustafa Halawi; Naeem Khan; Neil Blake
Journal:  Immun Inflamm Dis       Date:  2015-04-28

10.  Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B.

Authors:  Larissa K Martin; Alexandra Hollaus; Anna Stahuber; Christoph Hübener; Alessia Fraccaroli; Johanna Tischer; Andrea Schub; Andreas Moosmann
Journal:  PLoS Pathog       Date:  2018-04-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.